Market Research Logo

United States Neurological Diagnostic Equipment Market Outlook to 2023

United States Neurological Diagnostic Equipment Market Outlook to 2023

Summary

GlobalData’s new report, United States Neurological Diagnostic Equipment Market Outlook to 2023, provides key market data on the United States Neurological Diagnostic Equipment market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments - Electromyographs (EMG), Electroencephelographs (EEG), ICP Monitoring Devices, Magnetoencephalographs and Transcranial Dopplers.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Neurological Diagnostic Equipment market segments - Electromyographs (EMG), Electroencephelographs (EEG), ICP Monitoring Devices, Magnetoencephalographs and Transcranial Dopplers.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the United States Neurological Diagnostic Equipment market.
  • Key players covered include Natus Medical Incorporated, Nihon Kohden Corp, Integra LifeSciences Holdings Corp and Others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Neurological Diagnostic Equipment Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Neurological Diagnostic Equipment Market, United States
3.1 Neurological Diagnostic Equipment Market, United States, Revenue ($m), 2009-2016
3.2 Neurological Diagnostic Equipment Market, United States, Revenue ($m), 2016-2023
3.3 Neurological Diagnostic Equipment Market, United States, Volume (Units), 2009-2016
3.4 Neurological Diagnostic Equipment Market, United States, Volume (Units), 2016-2023
3.5 Neurological Diagnostic Equipment Market, United States, Average Price ($), 2009-2023
3.6 Neurological Diagnostic Equipment Market, United States, Distribution Share by Revenue ($m), 2015-2016
3.7 Neurological Diagnostic Equipment Market, United States, Company Share by Revenue ($m), 2016
4 Overview of Key Companies in United States, Neurological Diagnostic Equipment Market
4.1 Natus Medical Incorporated
4.1.1 Company Overview
4.2 Nihon Kohden Corp
4.2.1 Company Overview
4.3 Integra LifeSciences Holdings Corp
4.3.1 Company Overview
4.4 Elekta AB
4.4.1 Company Overview
4.5 DePuy Synthes Inc
4.5.1 Company Overview
4.6 Cadwell Industries Inc
4.6.1 Company Overview
5 Neurological Diagnostic Equipment Market Pipeline Products
6 Financial Deals Landscape
6.1 Equity Offerings
6.1.1 NeuroMetrix Raises USD21.3 Million in Private Placement of Shares and Warrants
6.2 Venture Financing
6.2.1 Neural Analytics Raises USD10.2 Million in Venture Financing
6.2.2 Neuro Kinetics Raises Additional USD1.8 Million in Venture Financing
7 Recent Developments
7.1 Corporate Communications
7.1.1 Apr 24, 2017: Purdue Pharma Names Josie Martin Head of Corporate Affairs & Communications
7.1.2 Apr 21, 2017: Henry Ford Cancer Institute Appoints Vice President, Executive Director
7.1.3 Apr 21, 2017: Purdue Pharma Announces Hire of Carrie Chomiak to Lead Over-the-Counter Franchise
7.1.4 Mar 28, 2017: Henry Ford Veteran Doctor Kimberly A. Brown to Help Lead Transplant Institute
7.1.5 Mar 24, 2017: Henry Ford Hospital Dermatologist Named Dermatology Chair
7.1.6 Mar 21, 2017: SPR Therapeutics Appoints Michael P. Chuisano to Board of Directors
7.1.7 Feb 07, 2017: Henry Ford Health System Names New Chair of Neurology Department
7.1.8 Jan 04, 2017: Henry Ford Health System Welcomes New President and CEO
7.1.9 Dec 05, 2016: Integra LifeSciences announces management changes
7.1.10 Dec 05, 2016: Integra LifeSciences Announces Key Executive Appointments
7.1.11 Nov 08, 2016: NeuroMetrix Announces Promotion of Frank McGillin to Chief Commercial Officer
7.1.12 Oct 05, 2016: Henry Ford Health System Announces New CEO of Health Alliance Plan
7.1.13 Sep 22, 2016: Natus Medical Announces Appointment Of Barbara R. Paul, M.d. To Its Board Of Directors
7.1.14 Jul 21, 2016: BrainScope Appoints Medical Device Industry Veteran Andrew Holman as Chief Commercial Officer
7.1.15 Jun 06, 2016: Renowned Diabetes Expert Named Inaugural Director of New Comprehensive Pediatric Diabetes Center at NYU Langone
7.2 Financial Announcements
7.2.1 May 03, 2017: Casmed Reports First-Quarter 2017 Financial Results
7.2.2 Apr 26, 2017: Integra LifeSciences Reports First Quarter 2017 Financial Results
7.2.3 Apr 26, 2017: Natus Medical Announces First Quarter 2017 Financial Results
7.2.4 Apr 20, 2017: NeuroMetrix Reports Q1 2017 Financial Results
7.2.5 Apr 20, 2017: Electrical Geodesics: Results for the year ended 31 December 2016
7.2.6 Mar 09, 2017: CASMED Reports 2016 Fourth-Quarter and Full-Year Financial Results
7.2.7 Mar 06, 2017: Electrical Geodesics: Business Update
7.2.8 Feb 23, 2017: Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance
7.2.9 Feb 01, 2017: Natus Medical Announces Fourth Quarter and Full Year 2016 Financial Results
7.2.10 Jan 26, 2017: NeuroMetrix Reports Q4 and Full Year 2016 Financial Results
7.2.11 Jan 10, 2017: NeuroMetrix Reports Strong Quell Demand in Q4 2016
7.2.12 Jan 10, 2017: CASMED Reports Preliminary Net Sales for the 2016 Fourth Quarter and Full Year
7.2.13 Nov 08, 2016: CASMED Reports Third-Quarter 2016 Financial Results
7.2.14 Oct 27, 2016: Integra LifeSciences Reports Third Quarter 2016 Financial Results
7.2.15 Oct 20, 2016: NeuroMetrix Reports Q3 2016 Financial Results
7.2.16 Oct 19, 2016: Natus Medical Announces Third Quarter 2016 Financial Results
7.2.17 Aug 29, 2016: Electrical Geodesics Announces Six Month Period of Strong Revenue Growth
7.2.18 Aug 26, 2016: Electrical Geodesics Announces A Period of Strong Revenue Growth
7.2.19 Aug 04, 2016: CASMED Reports Second-Quarter 2016 Financial Results
7.2.20 Jul 28, 2016: Electrical Geodesics Provides Trading Update
7.2.21 Jul 28, 2016: Integer Holdings Reports 2016 Second Quarter Results
7.2.22 Jul 28, 2016: Integra LifeSciences Reports Second Quarter 2016 Financial Results
7.2.23 Jul 21, 2016: NeuroMetrix Reports Q2 2016 Financial Results and Highlights
7.2.24 Jul 20, 2016: Natus Medical Announces Record Second Quarter 2016 Financial Results
7.3 Legal And Regulatory
7.3.1 Apr 03, 2017: Varian Medical Systems and Elekta Settle Patent Litigation
7.3.2 Jan 26, 2017: Henry Ford Cancer Institute Earns Distinct Level of Accreditation
7.3.3 Nov 15, 2016: Henry Ford Radiation Oncology Receives 3-Year ACR Accreditation
7.3.4 Jun 27, 2016: Greatbatch Renamed Integer Holdings
7.4 Other Significant Developments
7.4.1 Apr 03, 2017: Generous Foundation Grant to Help Start New Global Technology Development Program at Henry Ford Health System
7.4.2 Feb 27, 2017: Bristol-Myers Squibb Expands International Immuno-Oncology Network (II-ON) With Addition of Columbia University Medical Center and Peter MacCallum Cancer Centre
7.4.3 Sep 29, 2016: Croton Healthcare Canada, York Instruments & Simon Fraser University Undertake Clinical Study Of MEG Effectiveness In Diagnosing Brain Concussions
7.5 Product News
7.5.1 Apr 07, 2017: Deep Brain Stimulation Decreases Tics in Young Adults with Severe Tourette Syndrome
7.5.2 Mar 02, 2017: Study Finds New Mechanism to Control Information Flow in the Brain
7.5.3 Feb 21, 2017: Great Lakes NeuroTechnologies Receives Two Deep Brain Stimulation Programming Patents
7.5.4 Oct 18, 2016: Curelator Headache announces study with NYU Langone Medical Center to examine effectiveness of protective behaviors for migraineurs and post-concussive headache patients
7.6 Strategy And Business Planning
7.6.1 Mar 16, 2017: Nynex Therapeutics Launched to Target Oncogenic Proteins in the Treatment of Cancer
7.6.2 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Company Share Analysis
8.1.5 Distribution Share Analysis
8.1.6 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer
1.1 List of Tables
Table 1: Neurological Diagnostic Equipment Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 2: Neurological Diagnostic Equipment Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 3: Neurological Diagnostic Equipment Market, United States, Volume (Units), Historic, 2009-2016
Table 4: Neurological Diagnostic Equipment Market, United States, Volume (Units), Forecast, 2016-2023
Table 5: Neurological Diagnostic Equipment Market, United States, Average Price ($), Historic, 2009-2016
Table 6: Neurological Diagnostic Equipment Market, United States, Average Price ($), Forecast, 2016-2023
Table 7: Neurological Diagnostic Equipment Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 8: Neurological Diagnostic Equipment Market, United States, Company Share by Revenue ($m), USD Constant, 2016
Table 9: Neurological Diagnostic Equipment Market Pipeline Products
Table 10: NeuroMetrix Raises USD21.3 Million in Private Placement of Shares and Warrants
Table 11: Neural Analytics Raises USD10.2 Million in Venture Financing
Table 12: Neuro Kinetics Raises Additional USD1.8 Million in Venture Financing
1.2 List of Figures
Figure 1: Neurological Diagnostic Equipment Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 2: Neurological Diagnostic Equipment Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 3: Neurological Diagnostic Equipment Market, United States, Volume (Units), Historic, 2009-2016
Figure 4: Neurological Diagnostic Equipment Market, United States, Volume (Units), Forecast, 2016-2023
Figure 5: Neurological Diagnostic Equipment Market, United States, Company Share (%) 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report